Internal Medicine · La Jolla, CA
NPI
1306861950
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
3855 Health Sciences Dr, Mail Code 0820
La Jolla, CA, 92093
Phone (858) 534-5400
Groups this clinician bills Medicare through
Medicare paid, 2024
$43K
393 services
Medicare patients, 2024
195
Average age 75
Drug cost, 2024
$7.7M
857 prescriptions
Company payments, 2025
$5,598
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Thomas J Kipps was code 99215 (office e&m - established), 344 times for 172 patients. In total Thomas J Kipps billed 393 services in 9 codes, and Medicare paid $43K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-09-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 344 | 172 | $108.94 | $37K |
By year: 2022 $45K for 415 services; 2023 $40K for 385 services; 2024 $43K for 393 services.
Medicare prescription drug claims, 2024
In 2024, the drug Thomas J Kipps prescribed most often to Medicare patients was Imbruvica (Ibrutinib), with 156 prescriptions and refills. In total Thomas J Kipps wrote 857 Medicare prescriptions that cost $7.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Imbruvica Ibrutinib | 156 | 160 | 16 | $2.5M |
| Acyclovir Generic | 107 | 239 | 30 | $3,448 |
| Brukinsa Zanubrutinib | 100 | 100 | Under 11 | $1.4M |
| Calquence Acalabrutinib Maleate | 97 | 97 | 12 | $1.4M |
| Jaypirca Pirtobrutinib | 52 | 52 | Under 11 | $1.1M |
| Azithromycin Generic | 51 | 51 | 34 | $256 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 36 | 36 | 26 | $280 |
| Venclexta Venetoclax | 31 | 31 | Under 11 | $464K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 29 | 33 | 13 | $236 |
| Gammagard Liquid Immun Glob G(Igg)/Gly/Iga Ov50 | 28 | 28 | Under 11 | $170K |
| Revlimid Lenalidomide | 17 | 17 | Under 11 | $290K |
| Allopurinol Generic | 15 | 17 | Under 11 | $156 |
| Valacyclovir Valacyclovir Hcl | 14 | 28 | Under 11 | $1,338 |
| Hizentra Immun Glob G(Igg)/Pro/Iga 0-50 | 14 | 14 | Under 11 | $95K |
| Penicillin V Potassium Generic | 12 | 12 | Under 11 | $8.96 |
Brand drugs: 526 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Thomas J Kipps $5,598 ($2,455 in general payments such as food, travel and fees and $3,143 for research) from 10 companies. The largest payer was F. Hoffmann-La Roche AG with $3,143.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.